Related Experiment Video
Updated: Jun 26, 2026

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models
Published on: January 27, 2023
The mechanisms of hyperphosphatemia-induced vascular calcification
M Cozzolino1, M Gallieni, D Brancaccio
1Renal Division, S. Paolo Hospital, University of Milan, Milan, Italy. mariocozzolino@hotmail.com
Insights
Extensive arterial calcification is common in end-stage chronic kidney disease (CKD). Controlling serum phosphate is crucial to prevent vascular calcification and related complications in CKD patients.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Biochemistry
Background:
- Patients with end-stage chronic kidney disease (CKD stage 5) frequently exhibit extensive arterial and soft tissue calcification.
- Cardiovascular disease in renal failure is linked to significant alterations in bone metabolism.
- Hyperphosphatemia and secondary hyperparathyroidism are recognized contributors to cardiovascular calcification.
Discussion:
- Inorganic phosphate directly induces arterial calcification via "ossification" of the tunica media in CKD patients.
- This process involves more than just passive calcium-phosphate deposition.
- Understanding the direct mechanisms of phosphate-induced vascular damage is critical.
Key Insights:
- Serum phosphate control is paramount in managing CKD-related cardiovascular complications.
- Preventing elevated calcium x phosphate product is essential.
- Mitigating secondary hyperparathyroidism directly impacts vascular health.
Outlook:
- Further research into targeted phosphate-lowering therapies for CKD patients.
- Developing strategies to inhibit the "ossification" process in vascular smooth muscle cells.
- Improving long-term cardiovascular outcomes through comprehensive mineral and bone disorder management in CKD.
Abstract:
Extensive calcification of the arterial wall and soft tissues is a frequent feature of patients with end-stage chronic kidney disease (CKD stage 5). Hyperphosphatemia and secondary hyperparathyroidism have been extensively investigated as inducing factors in cardiovascular calcification. In fact, cardiovascular disease in renal failure is associated with bone metabolism alterations. Together with passive deposition of calcium-phosphate in extraskeletal tissues, it has recently been demonstrated that inorganic phosphate induces arterial calcification directly through a real "ossification" of the tunica media in the vasculature of CKD patients. Therefore, control of serum phosphate in CKD patients becomes crucial in preventing increases in calcium x phosphate product, secondary hyperparathyroidism, and ultimately vascular calcification.
Related Concept Videos
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Skeleton and Calcium Homeostasis
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Peripheral Artery Disease I: Introduction
Regulation of Angiogenesis and Blood Supply

